Literature DB >> 1825938

The relationship between sex steroids and bone mineral content in women soon after the menopause.

T D Spector1, P W Thompson, L A Perry, H H McGarrigle, A C Edwards.   

Abstract

Prevention of postmenopausal osteoporosis is now possible with current therapy, if initiated soon after the menopause and continued for at least 10 years. Simple ways of detecting those at risk of subsequent osteoporosis are urgently needed. This study investigated the hypothesis that certain serum sex hormones could predict bone mineral content (BMC) as measured by dual photon densitometry, soon after the menopause. The subjects included 136 healthy white females within 30 months of their last menstrual period with a mean age of 52 years. Of the sex hormones, the adrenal androgen dehydroepiandrosterone sulphate (DHEAS) correlated best with spinal BMC, a relationship which was significant using multiple regression (P = 0.02), although the correlation was weak (r = +0.19). A direct physiological role for DHEAS has yet to be found, despite being present in large quantities in serum, although it may act as a marker for other processes. No association was seen between testosterone, sex hormone binding globulin, oestradiol, oestrone and oestrone sulphate and spinal BMC. No significant correlations with any hormones were seen with femoral BMC. The data suggest that serum sex hormones are not useful markers of current bone mineral status soon after the menopause, although further work is needed to explore the relationship with DHEAS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825938     DOI: 10.1111/j.1365-2265.1991.tb01733.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Endogenous sex hormones and bone mineral density among community-based postmenopausal women.

Authors:  S Murphy; K T Khaw; M J Sneyd; J E Compston
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

2.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Authors:  Irene Lambrinoudaki; George Christodoulakos; Leon Aravantinos; Aristidis Antoniou; Demetrios Rizos; Constantinos Chondros; Apostolos Kountouris; Grigorios Chrysofakis; George Creatsas
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

4.  Associations between body morphology and bone mineral density in premenopausal women.

Authors:  P Orozco; J M Nolla
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

5.  Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.

Authors:  Michael A Ghebre; Deborah J Hart; Alan J Hakim; Bernet S Kato; Vicky Thompson; Nigel K Arden; Tim D Spector; Guangju Zhai
Journal:  Calcif Tissue Int       Date:  2011-07-26       Impact factor: 4.333

6.  Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women.

Authors:  R W Keen; T Nguyen; R Sobnack; L A Perry; P W Thompson; T D Spector
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.

Authors:  L Wang; Y-D Wang; W-J Wang; D-J Li
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

8.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.

Authors:  T Bellido; R L Jilka; B F Boyce; G Girasole; H Broxmeyer; S A Dalrymple; R Murray; S C Manolagas
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.

Authors:  G M Hall; L A Perry; T D Spector
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.